Neurontin is an anticonvulsant drug used to treat partial seizures and nervous system pain. Some serious side effects have been reported. These include respiratory disease, allergic reactions, and suicidal thoughts. There were lawsuits filed against the drug companies behind Neurontin for trying to get doctors to prescribe the medication for unapproved uses. Health care and insurance providers All persons or entities in the United States that purchased Neurontin from Pfizer at any time during the period of December 11, 2002 through August 31, 2008 and who have purchased generic gabapentin. Excluded from the Class are Defendants and each of their respective parents, employees, subsidiaries, afiliates, and franchisees, and all government entities. The FDA has warned that gabapentin and pregabalin, used to treat a range of conditions including pain and seizures, may cause serious breathing problems. Dr David Franklin, a former employee of the Warner- Lambert Pharmaceutical Company, has filed a lawsuit against the company, alleging that its sales representatives encouraged doctors to prescribe gabapentin (Neurontin) for unapproved uses. Gabapentin was approved by the Food and Drug Administration in 1994 for the treatment of epilepsy, including elementary partial seizures and complex A $190 million settlement has been reached in New York in a consumer fraud class action lawsuit pending against Pfizer which alleges the pharma giant engaged in tactics to delay market entry of generic versions of its epilepsy drug Neurontin. Legal Urge offers daily legal insights, news, and analysis to simplify complex laws. Explore expert content that informs, empowers, and sparks legal curiosity. Why is There a Lawsuit Against Gabapentin? The plaintiffs allege that the three pharmaceutical companies engaged in deceptive marketing, misbranding, and inadequate safety labeling in regards to gabapentin. This includes promotion of off-label uses while concealing risks like suicidal behavior and memory loss. Gabapentin, originally developed as an anticonvulsant, has gained notoriety for its use in treating neuropathic pain and other conditions. While it has provided relief to many, there's a growing concern regarding its safety profile. Lawsuits against manufacturers have emerged, alleging that they failed to adequately warn patients and healthcare providers about potential risks. This article Explore the potential for seeking compensation in gabapentin-related memory loss cases, including legal grounds, evidence, and filing deadlines. Los Angeles, CA: A $325 million preliminary settlement has been reached by Pfizer Inc and Warner-Lambert Co. LLC and plaintiffs who filed a consumer fraud class action lawsuit over the marketing Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses, its second settlement over the Neurontin Lawsuits Neurontin (generic name: gabapentin) was FDA-approved in 1993 for use as an anticonvulsant for people suffering from partial seizures associated with epilepsy. If you have suffered an injury after taking Neurontin, you may need to file a Neurontin lawsuit to get compensation. LegalMatch lawyers can help today. · The purpose of this notice is to alert you to a proposed settlement of a Class Action Lawsuit (the “Lawsuit”) brought by Direct Purchasers of Neurontin against Pfizer Inc. and Warner-Lambert Company LLC (collectively “Pfizer” or “Defendants”). The Lawsuit asserts that Pfizer violated antitrust laws relating to the sale of its prescription drug Neurontin. And it's the second settlement of Neurontin-related claims in less than 6 weeks. On April 21, Pfizer said it would pay $190 million to settle a federal antitrust lawsuit claiming that the company Gabapentin, commonly sold under the brand name Neurontin, is a prescription drug used to treat seizures, restless leg syndrome, and pain caused by shingles. While it has been effective for some patients, there have been several cases of adverse effects and potential health concerns associated with its use. In recent years, the manufacturers of Gabapentin have faced legal challenges as a result Pfizer, the world's largest drug maker, pleaded guilty on 13 May to numerous civil and criminal charges for illegally promoting the off-label use of gabapentin (Neurontin). It has agreed to pay a $240m (£136m; €200m) criminal fine and $152m to state and federal healthcare programmes. The fine is the second largest given in the industry. Meanwhile, off-label sales of gabapentin continue to The manufacturers of the drug Neurontin reached a $325 million class action lawsuit settlement Wednesday over allegations they fraudulently marketed the prescription drug, which is used to treat seizures, restless leg syndrome, and pain caused by shingles. If approved, third-party payers of the drug will be eligible to claim a cash award from the Neurontin class action settlement, announced The lawsuit claimed that Pfizer delayed competition from less expensive generic versions of Neurontin by executing a multifaceted scheme involving, among other things, improperly listing certain patents with the U.S. Food and Drug Administration. engaging in illegal promotion and sales of Neurontin for unapproved uses, filing and maintaining I have been taking Gabapentin for over 10 years, and it has really destroyed my teeth. I have Interstitial Cystitis and Fibromyalgia, and Gabapentin has helped me a great deal, so I need to keep taking it. I would definitely be interested in a Class Action lawsuit. If I could get my dental work done through this lawsuit I would be satisfied.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |